M. S. Topp Et Al. , "BLINATUMOMAB IMPROVED OVERALL SURVIVAL IN PATIENTS WITH RELAPSED OR REFRACTORY PHILADELPHIA NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IN A RANDOMIZED, OPEN-LABEL PHASE 3 STUDY (TOWER)," 21st Congress of the European-Hematology-Association , vol.101, Copenhagen, Denmark, pp.24-25, 2016
Topp, M. S. Et Al. 2016. BLINATUMOMAB IMPROVED OVERALL SURVIVAL IN PATIENTS WITH RELAPSED OR REFRACTORY PHILADELPHIA NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IN A RANDOMIZED, OPEN-LABEL PHASE 3 STUDY (TOWER). 21st Congress of the European-Hematology-Association , (Copenhagen, Denmark), 24-25.
Topp, M. S., Stein, A., Goekbuget, N., Fielding, A., Schuh, A., Ribera Santasusana, J. M., ... Wei, A.(2016). BLINATUMOMAB IMPROVED OVERALL SURVIVAL IN PATIENTS WITH RELAPSED OR REFRACTORY PHILADELPHIA NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IN A RANDOMIZED, OPEN-LABEL PHASE 3 STUDY (TOWER) . 21st Congress of the European-Hematology-Association (pp.24-25). Copenhagen, Denmark
Topp, M. Et Al. "BLINATUMOMAB IMPROVED OVERALL SURVIVAL IN PATIENTS WITH RELAPSED OR REFRACTORY PHILADELPHIA NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IN A RANDOMIZED, OPEN-LABEL PHASE 3 STUDY (TOWER)," 21st Congress of the European-Hematology-Association, Copenhagen, Denmark, 2016
Topp, M. S. Et Al. "BLINATUMOMAB IMPROVED OVERALL SURVIVAL IN PATIENTS WITH RELAPSED OR REFRACTORY PHILADELPHIA NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IN A RANDOMIZED, OPEN-LABEL PHASE 3 STUDY (TOWER)." 21st Congress of the European-Hematology-Association , Copenhagen, Denmark, pp.24-25, 2016
Topp, M. S. Et Al. (2016) . "BLINATUMOMAB IMPROVED OVERALL SURVIVAL IN PATIENTS WITH RELAPSED OR REFRACTORY PHILADELPHIA NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IN A RANDOMIZED, OPEN-LABEL PHASE 3 STUDY (TOWER)." 21st Congress of the European-Hematology-Association , Copenhagen, Denmark, pp.24-25.
@conferencepaper{conferencepaper, author={M. S. Topp Et Al. }, title={BLINATUMOMAB IMPROVED OVERALL SURVIVAL IN PATIENTS WITH RELAPSED OR REFRACTORY PHILADELPHIA NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IN A RANDOMIZED, OPEN-LABEL PHASE 3 STUDY (TOWER)}, congress name={21st Congress of the European-Hematology-Association}, city={Copenhagen}, country={Denmark}, year={2016}, pages={24-25} }